The 35th CINP World Congress of Neuropsychopharmacology

Session information

[CINP2024] Poster Session

CINP2024 » Poster Session

Schizophrenia 1 - Clinical (1)

Fri. May 24, 2024 5:30 PM - 6:30 PM CINP Poster Session Hall (Lobby Gallery)

*Dongmei Wang1,2, Xijing Chen1,2, Yang Tian1,2, Zhixuan Yu1,2, Dachun Chen3, Meihong Xiu3, Thomas Kosten4,5, Xiangyang Zhang1,2 (1. CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing, China, 2. Department of Psychology, University of Chinese Academy of Sciences, Beijing, China, 3. Beijing HuiLongGuan Hospital, Peking University, Beijing, China, 4. Mental Health Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA, 5. Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA)

*Tatsuro Marumoto1, Yosuke Saga1, Hiroaki Kinoshita2, Natsuko Morita2, Tokiko Touma3, Shinya Wakamatsu1, Kyoko Takebe2, Akihide Wakamatsu1, Chih-Lin Chiang1 (1. Medical Affairs Division, Janssen Pharmaceutical K.K., 2. Drug Safety Surveillance Department, Japan Safety & Surveillance Division, Janssen Pharmaceutical K.K., 3. Statistics & Decision Sciences Japan, Janssen Pharmaceutical K.K.)

*Tatsuro Marumoto1, Hiroshi Horio1, Hiroaki Kinoshita2, Natsuko Morita2, Tokiko Touma3, Kyoko Takebe2, Akihide Wakamatsu1 (1. Medical Affairs Division, Janssen Pharmaceutical K.K., 2. Drug Safety Surveillance Department, Japan Safety & Surveillance Division, Janssen Pharmaceutical K.K., 3. Statistics & Decision Sciences Japan, Janssen Pharmaceutical K.K.)

*Shinichiro Ochi1, Fumitoshi Kodaka2, Naomi Hasegawa3, Jun-ichi Iga1, Hiroko Kashiwagi3, Hiroshi Komatsu4, Hiromi Tagata5, Takashi Tsuboi6, Shusuke Numata7, Hitoshi Iida8, Shun Igarashi6, Kazutaka Ohi9, Kentaro Fukumoto10, Hiroyuki Muraoka11, Junya Matsumoto3, Kenichiro Miura3, Shu-ichi Ueno1, Koichiro Watanabe6, Ken Inada11, Ryota Hashimoto3, Norio Yasui-Furukori12 (1. Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Ehime, Japan, 2. Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan, 3. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 4. Department of Psychiatry, Tohoku University Hospital, Miyagi, Japan, 5. Department of Neuropsychiatry, Toho University School of Medicine, Tokyo Japan, 6. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan, 7. Department of Psychiatry, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan, 8. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan, 9. Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan, 10. Department of Neuropsychiatry, School of Medicine, Iwate Medical University, Iwate, Japan, 11. Department of Psychiatry, Kitasato University, School of Medicine, Kanagawa, Japan, 12. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan)

*Chian-Jue Kuo1,2,3, Wen-Yin Chen1,4, Pao-Huan Chen2,3, Shang-Ying Tsai2,3, Chiao-Chicy Chen2,3,5,6 (1. Taipei City Psychiatric Center, Taipei City Hospital, 2. Department of Psychiatry, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan, 3. Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan, 4. School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan, 5. Department of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwan, 6. Department of Psychiatry, Mackay Medical College, Taipei, Taiwan)

*Naoki Hashimoto1, Norio Yasui-Furukori2, Naomi Hasegawa3, Hikaru Hori4, Hitoshi Iida4, Kayo Ichihashi5, Kenichiro Miura3, Junya Matsumoto3, Shusuke Numata6, Fumitoshi Kodaka7, Ryuji Furihata8, Ken Inada9, Koichiro Watanabe10, Ryota Hashimoto3 (1. Department of Psychiatry, Hokkaido University Graduate School of Medicine, Hokkaido, Japan, 2. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan, 3. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan, 4. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan, 5. Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan, 6. Department of Psychiatry, Graduate School of Biomedical Science, Tokushima University, Tokushima, Japan, 7. Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan, 8. Agency for Student Support and Disability Resources, Kyoto University, Kyoto, Japan, 9. Department of Psychiatry, Kitasato University School of Medicine, Kanagawa, Japan, 10. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo, Japan)

*Bintang Arroyantri Prananjaya1, Miranti Dwi Hartanti2, Ziske Maritska Maritska3, Mgs Irsan Saleh Hasani4 (1. Department of Psychiatry, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia, 2. Department of Pharmacology, Faculty of Medicine, Universitas Muhammadiyah Palembang, Palembang, Indonesia, 3. Department of Biology Medicine, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia, 4. Department of Pharmacology, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia)

*Kazutaka Ohi1,2, Mihoko Shimada3, Midori Soda4, Daisuke Nishizawa5, Daisuke Fujikane1, Kentaro Takai1, Ayumi Kuramitsu1, Yukimasa Muto1, Shunsuke Sugiyama1, Junko Hasegawa5, Kiyoyuki Kitaichi4, Kazutaka Ikeda5, Toshiki Shioiri1 (1. Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan, 2. Department of General Internal Medicine, Kanazawa Medical University, Ishikawa, Japan, 3. Genome Medical Science Project (Toyama), National Center for Global Health and Medicine (NCGM), Tokyo, Japan, 4. Laboratory of Pharmaceutics, Department of Biomedical Pharmaceutics, Gifu Pharmaceutical University, Gifu, Japan, 5. Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan)

×

Authentication

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.

×

Please log in with your participant account.
» Participant Log In